eISSN: 2299-0038
ISSN: 1643-8876
Menopause Review/Przegląd Menopauzalny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank


6/2003
vol. 2
 
Share:
Share:
abstract:

Tibolone in hormone replacement therapy (part 1)

Artur J. Jakimiuk
,
Jacek Tomaszewski
,
Michał Bogusiewicz

(Prz Menopauz 2003, 6: 32–41)
Online publish date: 2003/12/16
View full text Get citation
 
Since over 40 years hormone replacement therapy (HRT) is a standard treatment for menopausal symptoms. Quality of life improvement caused by the use of HRT was regarded to be beneficial for bone and cardiovascular system. However, recent studies showed that the prolonged use of HRT may be associated with increased risk of breast cancer. Moreover, HERS and WHI trials changed accepted opinion on use of hormone therapy in the primary and secondary prevention of cardiovascular diseases. Tibolone, a drug acting by a unique mechanism, since 1988 has been widely used in over 70 countries. This review presents contemporary data on the effect of tibolone on the breast, bone, lipids and cardiovascular system.
keywords:

menopause, hormone replacement therapy, tibolone

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.